Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma

被引：11
|
作者：
Crisafulli, Ernesto [1 ]
Zanini, Andrea [2 ]
Pisi, Giovanna [3 ]
Pignatti, Patrizia [4 ]
Poli, Gianluigi [5 ]
Scuri, Mario [5 ]
Chetta, Alfredo [1 ]
机构：
[1] Univ Parma, Dept Clin & Expt Med, Resp Dis & Lung Funct Unit, Via Gramsci 14, I-43126 Parma, Italy
[2] Malcantonese Hosp, Giuseppe Rossi Fdn, Div Internal & Resp Med, Castelrotto, Switzerland
[3] Univ Hosp, Dept Paediat, Cyst Fibrosis Unit, Parma, Italy
[4] Salvatore Maugeri Fdn IRCCS, Allergy & Immunol Unit, Pavia, Italy
[5] Chiesi Farmaceut SpA, Parma, Italy
来源：
EXPERT REVIEW OF RESPIRATORY MEDICINE | 2016年 / 10卷 / 05期
关键词：
Asthma; small airways; inflammation; beclometasone dipropionate; formoterol fumarate; extrafine; fixed combination; pMDI; DPI; LONG-ACTING BETA(2)-AGONISTS; AIRWAY SMOOTH-MUSCLE; SINGLE INHALER; REAL-LIFE; BECLOMETHASONE DIPROPIONATE/FORMOTEROL; FLUTICASONE PROPIONATE; SCIENTIFIC RATIONALE; PATIENT PERSPECTIVES; ADULT PATIENTS; LUNG-FUNCTION;
D O I：
10.1586/17476348.2016.1161508
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Inhaled therapy is often considered the cornerstone of asthma management and international guidelines recommend combination therapy of inhaled corticosteroids (ICS) and long-acting-beta2-agonists (LABA) in a large proportion of asthmatic patients. The effectiveness of ICS/LABA is dependent on the correct choice of device and proper inhalation technique, this influences drug delivery and distribution along the bronchial tree, including the most peripheral airways. The fixed combination of beclometasone dipropionate/formoterol fumarate (BDP/FF) is the only extrafine formulation available in pressurized metered dose inhaler (pMDI) and in dry powder inhaler (DPI). Here, we focus on the recent significant advances regarding BDP/FF fixed combination for the treatment of asthma.
引用
收藏
页码：481 / 490
页数：10
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma
    Kuna, Piotr
    Govoni, Mirco
    Lucci, Germano
    Scuri, Mario
    Acerbi, Daniela
    Stelmach, Iwona
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 569 - 580
  • [2] High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma
    Corradi, Massimo
    Spinola, Monica
    Petruzzelli, Stefano
    Kuna, Piotr
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (05) : 492 - 502
  • [3] Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma
    Kuna, Piotr
    Jerzynska, Joanna
    Martini, Matteo
    Vele, Andrea
    Barneschi, Irene
    Mariotti, Fabrizia
    Georges, George
    Ciurlia, Giorgia
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (04):
  • [4] Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives
    Fabbri, Leonardo Michele
    Nicolini, Gabriele
    Olivieri, Dario
    Papi, Alberto
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (03) : 479 - 490
  • [5] Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/ formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England
    Orlovic, Martina
    Magni, Tiziana
    Lukyanov, Vasily
    Guerra, Ines
    Madoni, Alessandra
    RESPIRATORY MEDICINE, 2022, 201
  • [6] Pharmacokinetic/Pharmacodynamic Interactions Between Extrafine Beclomethasone Dipropionate and Formoterol Fumarate Components of a Fixed-Dose Combination for Asthma and COPD
    Georges, G.
    Lucardie, A.
    Garofalo, C.
    Beaudot, C.
    Cella, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] Effects of Single Inhaler Combinations of Extrafine Beclometasone Dipropionate, Formoterol Fumarate Plus Glycopyrronium (BDP/FF/G) and Extrafine Beclometasone Dipropionate Plus Formoterol Fumarate (BDP/FF) on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD
    Watz, H.
    Kirsten, A.
    Ludwig-Sengpiel, A.
    Mroz, R. M.
    Charretier, R.
    Varoli, G.
    Vele, A.
    Cortellini, M.
    Krull, M.
    Galkin, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] A clinical pharmacology study of fixed vs. free combination of inhaled beclometasone dipropionate and formoterol fumarate dry powder inhalers in asthmatic adolescents
    Chawes, Bo L.
    Govoni, Mirco
    Piccinno, Annalisa
    Kreiner-Moller, Eskil
    Vissing, Nadja H.
    Mortensen, Li
    Nilsson, Erik
    Bisgaard, Amalie
    Deleuran, Maja
    Skytt, Nanna
    Samandari, Nasim
    Acerbi, Daniela
    Bisgaard, Hans
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 1169 - 1171
  • [9] Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
    Singh, Dave
    Corradi, Massimo
    Spinola, Monica
    Papi, Alberto
    Usmani, Omar S.
    Scuri, Mario
    Petruzzelli, Stefano
    Vestbo, Jorgen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2917 - 2928
  • [10] BRONCHODILATING EFFECTS OF EXTRAFINE BECLOMETASONE DIPROPIONATE AND FORMOTEROL FUMARATE VIA PRESSURIZED METERED DOSE INHALER IN ASTHMATIC CHILDREN
    Pohunek, P.
    Scuri, M.
    Reznichenko, Y.
    Varoli, G.
    Mokia-Serbina, S.
    Baronio, R.
    Brzostek, J.
    Kaczmarek, J.
    PEDIATRIC PULMONOLOGY, 2014, 49 : S55 - S55
12345